Results 171 to 180 of about 207,197 (306)

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved.
Lene H. Garvey, Knut Brockow, Annick Barbaud, Charlotte G. Mortz, Gianfranco Calogiuri, Asli Gelincik, Osman O. Yeğit, Alla Nakonechna, Annette Wagner, Rik Schrijvers, Toon Ieven   +10 more
wiley   +1 more source

Challenges and future perspectives of enhanced passive safety surveillance of influenza vaccines in Europe. [PDF]

Ther Adv Drug Saf
Amaral de Avila Machado M, Gandhi-Banga S, Serradell L, Gallo S, Wagué S, Moore TM, Khromava A.   +6 more
europepmc   +1 more source

Maximizing public health benefits: Policy perspectives on coverage and cell-based influenza vaccines in the US. [PDF]

Hum Vaccin Immunother
Nguyen VH, Mould-Quevedo JF.
europepmc   +1 more source

Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe

Acta Paediatrica, EarlyView.
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner, Despina D. Briana, Gian Carlo Di Renzo   +2 more
wiley   +1 more source

A Monoclonal Antibody ELISA-Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines. [PDF]

Influenza Other Respir Viruses
Odin M, Schmeisser F, Soto J, Weir JP.
europepmc   +1 more source

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus [PDF]

, 2002
Bianchi, A.T.J., Boer, L.E.A., de, Heinen, P.P., Rijsewijk, F.A.   +3 more
core   +2 more sources

Influenza Vaccine [PDF]

Public Health Reports (1896-1970), 1958
openaire   +2 more sources

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

Acta Paediatrica, EarlyView.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz, Raz Somech, Dan Dominissini, Nathan Keller, Efrat Dresner, Michal Paret, Gilad Sherman, Guy Katzenellenbogen, Elina Gelman, Keren Asraf, Ram Doolman, Atar Lev, Amos J. Simon, Helly Vernitsky, Assaf Barg, Hana Golan, Amos Toren, Michal Stein   +17 more
wiley   +1 more source

Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines. [PDF]

NPJ Vaccines
Hernandez-Davies J, Felgner J, Strahsburger E, Laster J, Jain A, Yates T, Silzel E, Assis R, Nakajima R, Jasinskas A, Yeromin A, Pone EJ, Jan S, de la Maza LM, Liang L, Felgner P, Wagar LE, Gregory AE, Davies DH.   +18 more
europepmc   +1 more source

Statins, Influenza Vaccination and Influenza [PDF]

Journal of Infectious Diseases, 2016
openaire   +2 more sources